Can a Neo Genesis Lapras in a BGS 5 Slab Reach PSA 9?
No, a Neo Genesis Lapras in a BGS 5 slab cannot realistically reach a PSA 9 grade. The gap between a BGS 5 (Poor to Fair condition) and a PSA 9 (Mint)...
Category Pokemon
How Much Value Does a Pikachu Stamp Salamence Lose if It Drops from 8.5 to 6?
The specific pricing data for a Pikachu Stamp Salamence at grade 8.5 versus grade 6 doesn't appear in current online pricing databases or auction records,...
What Is the Process for Crossing a BGS 8 Jolteon to HGA?
There is no specific formalized process for "crossing a BGS 8 Jolteon to HGA" because crossing—the act of removing a card from one grading company's slab...
When Should You Regrade a BGS 6.5 HeartGold SoulSilver Tyranitar?
In most cases, you should not regrade a BGS 6.5 HeartGold SoulSilver Tyranitar. The fundamental problem is cost: BGS charges $25 for standard grading...
How Much Does a HGA 1 Mew Gain at SGC 2?
A direct price comparison between a Mew card graded HGA 1 and an identical card graded SGC 2 isn't available in publicly documented market data—this is a...
Is It Risky to Crack a SGC 2 Zacian for HGA Submission?
Yes, cracking a SGC 2 Zacian for HGA submission carries significant risk and is generally not worth the effort for most collectors.
What Happens if Your Beckett 5 Pikachu Stamp Lunala Drops to a 4 at PSA?
If your Beckett 5 Pikachu Stamp Lunala drops to a PSA 4 upon regrading, you're looking at a significant hit to both the card's market value and its...
If You Have a TAG 3 Tag Team Rayquaza, Should You Cross It to SGC?
Whether you should cross your TAG 3 Tag Team Rayquaza to SGC depends primarily on the card's current grade, its market demand, and the cost-benefit ratio...
Is It Risky to Crack a BGS 7.5 Metagross for TAG Submission?
Yes, cracking a BGS 7.5 Metagross to resubmit for a higher grade carries real financial risk that often outweighs the potential reward.
When Should You Regrade a PSA 3 Scarlet & Violet Arcanine?
Whether you should regrade a PSA 3 Scarlet & Violet Arcanine depends primarily on the card's condition potential and the cost-to-benefit ratio.